Sensata Technologies’ Cooperation Agreement with Elliott

On January 20, 2023, ViewRay, Inc. ("ViewRay"), which designs, manufactures and markets the MRIdian® MRI-Guided Radiation Therapy System, announced that it has reached an agreement with Hudson Executive Capital LP ("HEC"), a New York City-based value-oriented investor, to appoint a senior investment analyst and representative of HEC as an observer of the ViewRay Board of Directors (the "Board"), effective as of January 20, 2023. ViewRay has also agreed that the Board will appoint that observer to fill any vacancy on the Board arising during the term of the agreement. In connection with this announcement, ViewRay has also entered into a cooperation agreement with HEC, which currently owns approximately 8.7% of the Company's outstanding common stock. Pursuant to its agreement with ViewRay, HEC has agreed to customary standstill and voting commitments, among other provisions. Cravath is representing ViewRay in connection with the agreement.